2022 Volume 27 Issue 1 Pages 148-
We described three patients with central nervous system(CNS)disorders associated with the treatment with immune checkpoint inhibitor(ICI). A patient with myelitis showed mild improvement in neurological features and reduction in abnormal intraspinal highintensities on MRI after both the discontinuation of ICI and treatment with steroids. Second patient with encephalitis was underwent the treatment with steroids in addition to withdrawal of ICI, and his consciousness became clear with disappearing cranial abnormal highintensities on MRI. In third patient, asymptomatic hypertrophic pachymeningitis spontaneously disappeared after stopping ICI only. When we encounter a patient with CNS disorders associated with ICI, firstly ICI should be discontinued and additional immunological treatments such as steroids were recommend, especially in patients whose CNS features were deteriorated or those with myelitis.